BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12903552)

  • 1. [D2 pancreas-preserving lymphadenectomy in tumors of the upper third of the stomach].
    Liotta G; Federici O
    Tumori; 2003; 89(4 Suppl):67-9. PubMed ID: 12903552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer: Current status of lymph node dissection.
    Degiuli M; De Manzoni G; Di Leo A; D'Ugo D; Galasso E; Marrelli D; Petrioli R; Polom K; Roviello F; Santullo F; Morino M
    World J Gastroenterol; 2016 Mar; 22(10):2875-93. PubMed ID: 26973384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic pancreas- and spleen-preserving D2 lymph node dissection in advanced (cT2) upper-third gastric cancer.
    Hur H; Jeon HM; Kim W
    J Surg Oncol; 2008 Feb; 97(2):169-72. PubMed ID: 18095269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
    Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
    J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extent of resection in surgery of stomach carcinoma].
    Sendler A; Etter M; Böttcher K; Siewert JR
    Chirurg; 2002 Apr; 73(4):316-24. PubMed ID: 12063915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spleen-preserving D2-lymphodissection in gastric cancer surgery].
    Stilidi IS; Nered SN; Glukhov EV
    Khirurgiia (Mosk); 2015; (1):41-43. PubMed ID: 25909550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding pancreatic necrosis following pancreas-preserving D3 lymphadenectomy for gastric cancer.
    Pacelli F; Doglietto GB; Alfieri S; Carriero C; Malerba M; Crucitti P; Crucitti F
    Br J Surg; 1998 Jan; 85(1):125-6. PubMed ID: 9462403
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
    Schmid A; Thybusch A; Kremer B; Henne-Bruns D
    Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphadenectomy: indications--technic--invasion--documentation].
    Lange J; Siewert JR
    Langenbecks Arch Chir; 1987; 372():587-92. PubMed ID: 3431271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
    Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
    Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
    Cheong O; Kim BS; Yook JH; Oh ST; Park YK; Ryu SY
    J Surg Oncol; 2008 Dec; 98(7):500-4. PubMed ID: 18770520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node dissection in resectable advanced gastric cancer.
    de Steur WO; Dikken JL; Hartgrink HH
    Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis.
    Jiang L; Yang KH; Guan QL; Zhao P; Chen Y; Tian JH
    J Surg Oncol; 2013 Jun; 107(8):807-14. PubMed ID: 23512524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma.
    Li C; Kim S; Lai JF; Oh SJ; Hyung WJ; Choi WH; Choi SH; Zhu ZG; Noh SH
    Eur J Surg Oncol; 2009 Jul; 35(7):709-14. PubMed ID: 18455906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Volumes of lymphadenectomy in gastric cancer surgery].
    Chernyavskij AA; Lavrov NA
    Khirurgiia (Mosk); 2015; (3):26-33. PubMed ID: 26031947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.